Perspective Therapeutics, Inc.
General ticker "CATX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $264.2M (TTM average)
Perspective Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -3.5%.
Estimated limits based on current volatility of 3.8%: low 2.71$, high 2.92$
Factors to consider:
- Total employees count: 163 (+18.1%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Economic downturns and volatility, Regulatory and compliance, Capital requirements, Manufacturing issues, Market acceptance
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.69$, 4.43$]
- 2026-12-31 to 2027-12-31 estimated range: [1.91$, 4.78$]
Financial Metrics affecting the CATX estimates:
- Positive: with PPE of -2.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Investing cash flow per share per price, % of 20.05 > 2.08
- Positive: 69.38 < Shareholder equity ratio, % of 77.55 <= 81.92
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
Short-term CATX quotes
Long-term CATX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1.43MM | $1.43MM | $0.88MM |
| Operating Expenses | $42.38MM | $92.31MM | $114.45MM |
| Operating Income | $-40.94MM | $-90.89MM | $-113.56MM |
| Non-Operating Income | $0.83MM | $10.46MM | $9.14MM |
| Interest Expense | $0.08MM | $0.05MM | $0.38MM |
| R&D Expense | $21.31MM | $41.64MM | $84.22MM |
| Income(Loss) | $-40.11MM | $-80.43MM | $-104.43MM |
| Taxes | $-2.65MM | $-2.10MM | $-0.79MM |
| Other Income(Loss) | $-9.05MM | $-0.95MM | $0.51MM |
| Net Income(Loss)* | $-46.51MM | $-79.28MM | $-103.12MM |
| Stockholders Equity | $75.18MM | $290.67MM | $207.03MM |
| Assets | $97.89MM | $341.10MM | $266.97MM |
| Operating Cash Flow | $-36.91MM | $-18.29MM | $-82.48MM |
| Capital expenditure | $1.07MM | $54.41MM | $12.75MM |
| Investing Cash Flow | $24.37MM | $-218.93MM | $41.23MM |
| Financing Cash Flow | $0.79MM | $289.38MM | $10.30MM |
| Earnings Per Share** | $-0.85 | $-1.23 | $-1.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.